View drug registration information details.
| Items | Registration information |
|---|
| ID | 378 |
|---|
| No | 378 |
|---|
| Brand Name | DAPAZIN 5 MG |
|---|
| Ingredients | DAPAGLIFLOZIN INN 5 MG |
|---|
| Dosage Form | SYRUP |
|---|
| Primary Packaging | ALU-ALU BLISTER |
|---|
| Storage | |
|---|
| Shelf Life | 2 YEARS |
|---|
| Pack Size | BOX OF 2 X 14'S |
|---|
| Dispensing Category | |
|---|
| ATC Classification | |
|---|
| Pharmaceutical Class | |
|---|
| Indications | TO REDUCE THE RISK OF SUSTAINED EGFR DECLINE, END STAGE KIDNEY DISEASE, CARDIOVASCULAR DEATH AND HOSPITALIZATION FOR HEART FAILURE IN ADULTS WITH CHRONIC KIDNEY DISEASE AT RISK OF PROGRESSION, AS AN ADJUNCT TO DIET AND EXCERCISE TO IMPROVE GLYCEMIC CONTROL IN ADULTS WITH TYPE 2 DIABETES MELLITUS |
|---|
| Contraindications | |
|---|
| Side Effects | |
|---|
| Unit Price | |
|---|
| EDL |
NULL |
|---|
| Description | GREEN COLOR DIAMOND SHAPED FILM COATED TABLET HAVING ENGRAVED CONCORD ON ONE SIDE AND BREAK LINE ON OTHER SIDE |
|---|
| Note | |
|---|
| License Owner | CITI TRADE IMPORT-EXPORT SOLE CO.,LTD |
|---|
| Manufacturer | CONCORD PHARMACEUTICAL LTD |
|---|
| Country | BANGLADESH |
|---|
| Import Registration No | |
|---|
| Import Registration Date | |
|---|
| Activity | CERTIFICATE RELEASED |
|---|
| Applied Date | |
|---|
| FDD Registration No | 02 I 5883/25 |
|---|
| FDD Registration Date | 2025-02-24 |
|---|
| Expiry Date | 2030-02-23 |
|---|
Back to drug list
|
